Search filters

List of works by Michael Boe Møller

A child with mastocytosis and lymphomatoid papulosis

scientific article published on 14 April 2016

A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry

scientific article published on 28 January 2015

A5.27 Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

scientific article published on 13 June 2017

Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma

scientific article published in March 1999

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

scientific article published on 17 June 2013

Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.

scientific article

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

scientific article

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

scientific article published on 05 November 2020

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

scientific article

Association of testicular non-Hodgkin's lymphomas with elevated serum levels of human chorionic gonadotropin-like material

scientific article published on 01 March 1996

Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia

scientific article published on 01 November 2007

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

scientific article published on 23 January 2013

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

scientific article

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.

scientific article published on 4 May 2018

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

scientific article published on 29 February 2016

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

scientific article published on March 2015

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

scientific article

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

scientific article

Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia

scientific article

Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1

scientific article published on 01 June 1999

Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort

scientific article

Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosis.

scientific article published on 16 May 2016

Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta

scholarly article by Beat H. Walpoth et al published May 2013 in Cardiovascular Pathology

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.

scientific article published on 12 July 2017

Conditional survival of patients with diffuse large B-cell lymphoma

scientific article published in May 2006

Cyclin D3 Expression in Non-Hodgkin Lymphoma

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas

scientific article

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.

scientific article published on 18 May 2017

Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation

scientific article published on 24 November 2008

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

scientific article published on 01 February 2022

Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL

scientific article

Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour

article

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

scientific article

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

scientific article published in January 2004

Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma

scientific article published on 01 May 1999

Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results

scientific article published on 22 April 2016

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

scientific article published on March 2015

Effect of implantation site on outcome of tissue-engineered vascular grafts

scientific article published on 17 April 2019

Epidemiology of systemic mastocytosis in Denmark.

scientific article

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

scientific article

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

scientific article

Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry

scientific article published on 23 July 2014

Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.

scientific article published on 5 August 2013

Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage.

scientific article

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.

scientific article published on 26 October 2015

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

scientific article published on 20 May 2016

Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma

scientific article

Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.

scientific article

Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.

scientific article published in May 2000

HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort

scientific article published on 11 August 2015

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

scientific article published on 26 September 2017

Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.

scientific article published on 22 February 2013

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia

scientific article published on 6 March 2015

High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma

scientific article published on 16 April 2014

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma

scientific article published in April 2012

High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden

scientific article published in April 2008

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

scientific article published on 11 February 2019

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

scientific article published on 4 June 2012

Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay

scientific article published on March 2011

Infantile hemophagocytic lymphohistiocytosis in a case of chediak-higashi syndrome caused by a mutation in the LYST/CHS1 gene presenting with delayed umbilical cord detachment and diarrhea

scientific article published on March 2015

KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis

scientific article published on 12 April 2013

KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis

scientific article published on 14 June 2013

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations

scientific article published on 11 November 2015

Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

scientific article published in February 2009

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

scientific article published in July 2013

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

scientific article

Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.

scientific article published on September 2015

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

scientific article published on 27 August 2013

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

scientific article published on 28 February 2013

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation

scientific article published on December 1999

Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index

scientific article published in April 2006

Microarray-based classification of diffuse large B-cell lymphoma

scientific article

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

article

Molecular control of the cell cycle in cancer: biological and clinical aspects.

scientific article

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements

scientific article published on 09 August 2018

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus

scientific article published on 22 December 2015

Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.

scientific article

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

scientific article

Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma

scholarly article by Hanne E. H. Møller et al published 28 September 2018 in European Journal of Haematology

Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate

scientific article published in October 2010

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

scientific article

NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.

scientific article

Non-Hodgkin's lymphoma of the spermatic cord

scientific article published on January 1994

Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.

scientific article published on 21 January 2015

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.

scientific article published on 29 June 2017

Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities

scientific article published on 01 November 1999

Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.

scientific article published on 18 November 2014

P27 in cell cycle control and cancer.

scientific article

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Prog

scientific article published on 21 January 2019

Paclitaxel-Eluting Biodegradable Synthetic Vascular Prostheses: A Step Towards Reduction of Neointima Formation?

scientific article published on 01 September 2009

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis

scientific article published on 19 May 2017

Pediatric Expression of Mast Cell Activation Disorders

scientific article published on 21 May 2018

Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study

scientific article

Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma

scientific article published on October 2017

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

scientific article published on 19 March 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

scientific article

Primary thymic extranodal marginal zone B cell lymphoma as an incidental finding in a Caucasian woman

scientific article published on 3 September 2015

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups

scientific article published on 7 November 2007

Prognosis of localized diffuse large B-cell lymphoma in younger patients

scientific article published in August 2003

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

scientific article published on 7 August 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

scientific article

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

scientific article published on 12 November 2015

Prognostic significance of metallothionein in B-cell lymphomas

scientific article published on 25 July 2006

Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis

scientific article published on 22 April 2017

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.

scientific article published on 16 March 2015

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

article

Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified

scientific article published on 01 October 2018

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow

scientific article published on 12 July 2007

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

scientific article published on 13 December 2013

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

scientific article

Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood.

scientific article published in August 2014

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

scientific article published on 08 December 2016

Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.

scientific article published on 30 August 2014

Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma

scientific article

Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study

scientific article published on 18 July 2016

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis

scientific article published on 21 February 2014

Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis

scientific article published on 28 June 2013

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

scientific article published on 20 March 2013

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

scientific article published on 17 June 2008

Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a

scientific article

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.

scientific article published on 15 May 2008

Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.

scientific article published on 31 January 2012

TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma

scientific article

Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis

scientific article

Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.

scientific article published in January 1994

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype

scientific article published on 23 October 2007

Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood

scientific article published on 09 May 2018

Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue

scientific article

Venom anaphylaxis can mimic other serious conditions and disclose important underlying disease

scientific article published on 01 March 2018

[Hip pain as a paraneoplastic rheumatic syndrome in a patient with double-hit lymphoma] ⬇️

scientific article published on 01 December 2014

[Mastocytosis]. ⬇️

scientific article

[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]

scientific article published on 01 September 2006

[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation]

scientific article published on 01 September 2006

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

scientific article published on 14 February 2016

Paulina is supported by:

About Paulina

Help